Introduction to the AHSN Network Nuala Foley Industry

  • Slides: 18
Download presentation
Introduction to the AHSN Network Nuala Foley Industry Engagement Manager KSS AHSN #AHSNs @AHSNNetwork

Introduction to the AHSN Network Nuala Foley Industry Engagement Manager KSS AHSN #AHSNs @AHSNNetwork

A connected ‘Network of Networks’

A connected ‘Network of Networks’

We are catalysts for innovation We connect partners across sectors We create the right

We are catalysts for innovation We connect partners across sectors We create the right environment for change We are collaborators

Our continuing mission is to spread healthcare innovation at pace and scale Improving health

Our continuing mission is to spread healthcare innovation at pace and scale Improving health Driving down costs Stimulating economic growth

AHSNs work locally Each AHSN is embedded in its regional health and care community

AHSNs work locally Each AHSN is embedded in its regional health and care community

… and nationally Each AHSN is part of the national AHSN Network: • a

… and nationally Each AHSN is part of the national AHSN Network: • a unique collaborative of expertise and experience • sharing learning • pooling intelligence • benefitting from a pipeline of emerging and proven solutions from around the country

Stimulating economic growth Mobilising the value the NHS can add as an economic asset

Stimulating economic growth Mobilising the value the NHS can add as an economic asset within the UK economy

The Innovation Exchange AHSNs support the regional ‘import and export’ of healthcare innovation through

The Innovation Exchange AHSNs support the regional ‘import and export’ of healthcare innovation through our Innovation Exchange. Four structured elements: 1. 2. 3. 4. needs definition innovator support and signposting real world validation spread and adoption of supported innovations

Why ‘complexity’? Many promising technological innovations in health and social care characterized by non-adoption

Why ‘complexity’? Many promising technological innovations in health and social care characterized by non-adoption or abandonment by individuals or by failed attempts to scale up locally, spread distantly, or sustain the innovation long term at the organization or system level. (Greenhalgh et al. Beyond adoption: (2017))

What stage is your company at?

What stage is your company at?

Where do you need support? MARKET READINESS Clinical Validation: utility, patients, health economics Clinical

Where do you need support? MARKET READINESS Clinical Validation: utility, patients, health economics Clinical Development: trials, protype, clinical efficacy Market Research: market testing, competitors, need Real World Validation: usability testing, pilot(s), case study Path to adoption and scale Pre - AHSN Technical Feasible Desirable Viable Spread: introductions, scale, implementation

Early Innovator Support MARKET READINESS Clinical Development: trials, protype, clinical efficacy Clinical Validation: utility,

Early Innovator Support MARKET READINESS Clinical Development: trials, protype, clinical efficacy Clinical Validation: utility, patients, health economics Pre - AHSN Market Research: market testing, competitors, need Real World Validation: usability testing, pilot(s), case study Path to adoption and scale Spread: introductions, scale, implementation

Next Steps

Next Steps

Bridging the Gap Programme • Market Insight Briefings – Health Warning • Innovation Surgeries

Bridging the Gap Programme • Market Insight Briefings – Health Warning • Innovation Surgeries – Health Check • Real world Validation – Evaluation in practice • Spread and Adoption - Acceleration

What now? Market Insight Briefings: • • 9 7 3 9 July August September

What now? Market Insight Briefings: • • 9 7 3 9 July August September October UCL Partners London Book via: kssahsn. bridgingthegap@nhs. net